Child Study Center Grand Rounds: "Rapid-acting Treatments for Pediatric Depression and Suicidality: Where are We Now?"

Pediatric depression and suicide are significant public health problems; when patients remain symptomatic after first-line depression treatments, there is little guidance for clinicians beyond the TORDIA-inspired recommendations, developed over a decade ago. Rapid-acting anti-depressants present a novel, active area of investigation across Psychiatry; here we discuss the current data

available for rapid-acting treatments in pediatric patients and identify the areas that require more research.